Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 1994
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Anti-Arrhythmia Agents (MeSH)
- Arrhythmias, Cardiac (MeSH)
- Atrial Fibrillation (MeSH)
- Canada (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Death, Sudden (MeSH)
- Defibrillators, Implantable (MeSH)
- Drug Evaluation (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Myocardial Infarction (MeSH)
- Placebos (MeSH)
- Ventricular Fibrillation (MeSH)
published in
- Canadian Journal of Cardiology Journal